Journal of Oncology

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours


Publishing date
07 Dec 2012
Status
Published
Submission deadline
10 Aug 2012

1Endocrinology Unit, Regina Elena Cancer Institute-IFO, Rome, Italy

2Department of Endocrinology, University Medical Center Groningen, Groningen, The Netherlands

3Fujairah Hospital, Fujairah Emirate, UAE


New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours

Description

In the recent years, we have witnessed many new diagnostic strategies for endocrine tumours, such as biochemical markers and somatostatin receptor imaging, as well as PET imaging with specific tracers like 5-HTP and DOPA. Also, a number of new therapies have been introduced in the clinical arena like somatostatin analogues. Yet, endocrine tumours are rare diseases, often very aggressive, with a poor prognosis, and we need to combine current expertise for the benefit of quality of life and survival rates of our patients.

This special issue aims to discuss the various aspects of diagnosis and treatments in aggressive endocrine tumours, in order to give to affected patients an optimal multimodal management, and the important contributions for this from the fields of genetics, proteomics, clinical chemistry, pathology, radiology, and nuclear medicine.

We invite authors to contribute original as well as review articles regarding the prognosis and therapy in aggressive endocrine tumours, the evaluation of the present outcomes, and the development of future diagnostic and treatment options. We are particularly interested in papers describing new nonsurgical approaches and less invasive procedures, with particular attention to cell-based therapy. The authors are asked to report a critical evaluation of these treatment options, showing their results and complications. Potential topics include, but are not limited to:

  • Cellular models and epigenetic in endocrine tumours
  • Animal models of endocrine tumours
  • Insulin and IGF 1 pathway in endocrine tumour carcinogenesis
  • New diagnostic imaging strategies in endocrine tumours
  • New targets and pathways of therapy
  • Current strategies in advanced hormone-dependent tumours: new targets of therapy?
  • Neuroendocrine (including carcinoid) tumours
  • Paraneoplastic (endocrine/metabolic) syndrome of solid & soft tumours
  • Adrenal cortical cancers: state-of-the-art treatment
  • Diagnostics of endocrine tumours in multiple endocrine neoplasia
  • Advances in surgical management of metastases of endocrine tumours
  • Current treatment options for disseminated parathyroid carcinoma

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 820938
  • - Editorial

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours

Marialuisa Appetecchia | Bruce H. R. Wolffenbuttel | Saadi Al Jadir
  • Special Issue
  • - Volume 2012
  • - Article ID 705036
  • - Review Article

Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2

C. Romei | E. Pardi | ... | R. Elisei
  • Special Issue
  • - Volume 2012
  • - Article ID 391629
  • - Review Article

New Treatment in Advanced Thyroid Cancer

Dario Giuffrida | Angela Prestifilippo | ... | Stefania Marchisotta
  • Special Issue
  • - Volume 2012
  • - Article ID 234726
  • - Review Article

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art

Amir H. Lebastchi | John W. Kunstman | Tobias Carling
  • Special Issue
  • - Volume 2012
  • - Article ID 749030
  • - Clinical Study

Merkel Cell Carcinoma: A Retrospective Study on 48 Cases and Review of Literature

Fernando Cirillo | Marco Vismarra | ... | Mario Martinotti
  • Special Issue
  • - Volume 2012
  • - Article ID 408131
  • - Review Article

Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment

Antonio Stigliano | Lidia Cerquetti | ... | Vincenzo Toscano
  • Special Issue
  • - Volume 2012
  • - Article ID 685213
  • - Review Article

Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to Ectopics

Carlotta Pozza | Chiara Graziadio | ... | Andrea M. Isidori
  • Special Issue
  • - Volume 2012
  • - Article ID 320198
  • - Clinical Study

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

A. Filice | A. Fraternali | ... | A. Versari
  • Special Issue
  • - Volume 2012
  • - Article ID 635614
  • - Review Article

The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis

Roberta Malaguarnera | Alaide Morcavallo | Antonino Belfiore
  • Special Issue
  • - Volume 2012
  • - Article ID 872713
  • - Review Article

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

Gabriele Parenti | Benedetta Zampetti | ... | Massimo Mannelli
Journal of Oncology
 Journal metrics
Acceptance rate24%
Submission to final decision66 days
Acceptance to publication37 days
CiteScore1.400
Impact Factor2.206
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.